Precocious puberty caused by McCune-Albright syndrome in a girl aged 6 years and 9 months;Przedwczesne dojrzewanie płciowe w zespole McCune-Albrighta u dziewczynki w wieku 6 lat i 9 miesiȩcy

Endokrynologia, Diabetologia i Choroby Przemiany Materii Wieku Rozwojowego

Volumn 12, Issue 1, 2006, Pages 63-67

  Wikiera, Beata ^a   Wawro, Józef ^a   Noczyńska, Anna ^a  

^a Katedra i Klinika Endokrynologii   (Poland)

Author keywords

"cafe au lait" spots; McCune Albright syndrome; Polyostotic fibrous dysplasia; Precocious puberty

Indexed keywords

ESTRADIOL; GONADORELIN; GONADOTROPIN;

ALBRIGHT SYNDROME; ARTICLE; BONE DYSPLASIA; BREAST DEVELOPMENT; CAFE AU LAIT SPOT; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; FEMALE; HUMAN; MAXILLARY SINUS; MENARCHE; OVARY CYST; PRECOCIOUS PUBERTY; PRESCHOOL CHILD; RADIOGRAPHY; SCINTIGRAPHY; SPHENOID SINUS; TIBIA;

CAFE-AU-LAIT SPOTS; CHILD; FACIAL BONES; FEMALE; FIBROUS DYSPLASIA, POLYOSTOTIC; HUMANS; OVARIAN CYSTS; PUBERTY, PRECOCIOUS; SKULL; TIBIA;

EID: 33645981001     PISSN: 1234625X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Lania A., Mantovani G., Spada A.: G protein mutations in endocrine diseases. Eur. J. Endocrinol., 2001, 145, 543.
2. Laven J., Lumbroso S., Sultan C., Fauser B.: Dynamics of ovarian function in an adult woman with McCune-Albright Syndrome. J. Clin. Endocrinol. Metab., 2001, 86, 2625.
3. Albers N., Jorgens S., Deiss D, Hauffa B.P.: McCune-Albright syndrome - the German experience. J. Pediatr. Endocrinol. Metab., 2002, 15, supl. 3, 897.
4. Eugster E.A., Rubin S.D., Reiter E.G. i wsp.: McCune-Albright Study Group. Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial. J Pediatr., 2003, 143, 60.
5. Lumbroso S., Paris F., Sultan C.: Activating Gs(Mutations: analysis of 113 patients with signs of McCune-Albright syndrome - a European collaborative study. J. Clin. Endocrinol. Metab., 2004, 89, 2107.
6. Roth C., Freiberg C., Zappel H., Albers N.: Effective aromatase inhibition by anastrozole in a patient with gonadotropin-independent precocious puberty in McCune-Albright syndrome. J. Pediatr. Endocrinol. Metab., 2002, 15, supl. 3, 945.
7. Silva E., Lumbroso S., Medina M. i wsp.: Demonstration of McCune-Albright mutations in the liver of children with γGT progressive cholestasis. J. Hepatol., 2000, 32, 154.
8. McCune D.J.: Osteitis fibrosa cystica; the case of a nine year old girl who also exhibits precocious puberty, multiple pigmentation of the skin and hyperthyroidism. Am. J. Dis. Child., 1936, 52, 743.
9. Albright F., Butler A.M., Hampton A.O., Smith P.: Syndrome characterized by osteitis fibrosa disseminate, areas of pigmentation and endocrine dysfunction with precocious puberty in females. N. Engl. J. Med., 1937, 216, 727.
10. Pacanowska M.: Przypadek dysplazji włóknistej kości. Pediatr. Pol., 1954, 29, 617.
11. Landis C.A., Masters S.B., Spada A. i wsp.: GTPase inhibiting mutations activate the (chain of Gs and stimulate adenylyl cyclase in human pituitary tumors. Nature, 1989, 330, 566.
12. Lyons J., Landis C.A., Harsch G. i wsp.: Two G protein oncogenes in human endocrine tumors. Science, 1990, 249, 655.
13. Mantovani G., Bondioni S., Lania A.G. i wsp.: Parental origin of Gs alpha mutations in the McCune-Albright syndrome and in isolated endocrine tumors. J. Clin. Endocrinol. Metab., 2004, 89, 3007.
14. Pienkowski C., Lumbroso S., Bieth E. i wsp.: Recurrent ovarian cyst and mutation of the Gs alpha gene in ovarian cyst fluid cells: what is the link with McCune-Albright syndrome? Acta Paediatr., 1997, 86, 1019.
15. Starzyk J., Urbanowicz W., Starzyk B., Januś D.: Wstȩpne wyniki leczenia tamoksifenem dziewczynek z zespołem McCune-Albrighta oraz nawracaja̧cymi torbielami pȩcherzykowymi jajników. Endokrynol. Pediatr., 2005, 4, 45.
16. Coutant R., Lumbroso S., Rey R. i wsp.: Macroorchidism due to autonomous hyperfunction of Sertolli cells and Gsa gene mutation: an unusual expression of McCune-Albright syndrome in a prepubertal boy. J. Clin. Endocrinol. Metab., 2001, 86, 1778.
17. Zacharin M.: Paediatric management of endocrine complications in McCune-Albright syndrome. J. Pediatr. Endocrinol. Metab., 2005, 18, 33.
18. Bareille P., Azcona C., Stanhope R.: Multiple neonatal endocrinopathies in McCune-Albright syndrome. J. Paediatr. Child Health, 1999, 35, 315.
19. Klatka M.: Przypadek pełnoobjawowego zespołu Albrighta u dziewczynki 1 4/12. Pediatr. Pol., 1992, 67, 29.
20. Kowalik S., Janicki W., Halczy-Kowalik L., Mazurek L.: Zwyrodnienie włókniste kości twarzy i czaszki. Otolaryngol. Pol., 1996, 50, 263.
21. Kowalski H., Wełniak M., Wróbel M.: Dysplasia fibrosa szczȩki u dzieci jako problem klinicznie nie rozwia̧zany. Ann. AM Siles., 1991, 22.
22. Kulczyński B., Mielcarek-Kuchta D.: Osteodysplasia twarzoczaszki. Otolaryngol. Pol., 1999, 53, 635.
23. Hannon T., Noonan K., Steinmetz R. i wsp.: Is McCune-Albright syndrome overlooked in subjects with fibrous dysplasia of bone? J. Pediatr., 2003, 142, 532.
24. Kitagawa Y., Tamai K., Ito H.: Oral alendronate treatment for polyostotic fibrous dysplasia: a case report. J. Orthop. Sci., 2004, 9, 521.
25. Plotkin H., Rauch F., Zeitlin L. i wsp.: Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone. J. Clin. Endocrinol. Metab., 2003, 88, 4569.